Daiwa Securities Group Inc. - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 61 filers reported holding TRANSLATE BIO INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$4,000
+100.0%
1400.0%0.00%
Q1 2021$2,000
-33.3%
1400.0%0.00%
Q4 2020$3,000
-40.0%
140
-59.2%
0.00%
Q3 2020$5,000
+66.7%
343
+19.5%
0.00%
Q2 2020$3,0000.0%2870.0%0.00%
Q1 2020$3,000
+50.0%
2870.0%0.00%
Q4 2019$2,000
-33.3%
2870.0%0.00%
Q3 2019$3,000
-25.0%
2870.0%0.00%
Q2 2019$4,000
+33.3%
2870.0%0.00%
Q1 2019$3,000
-40.0%
287
-55.8%
0.00%
Q4 2018$5,0006500.00%
Other shareholders
TRANSLATE BIO INC shareholders Q2 2019
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 3,922,008$29,415,00015.52%
Omega Fund Management, LLC 2,437,603$18,282,00013.56%
DAFNA Capital Management LLC 228,939$1,717,0000.85%
Baupost Group 6,491,287$47,136,0000.41%
Rock Springs Capital Management LP 1,009,179$7,569,0000.36%
Bain Capital Public Equity Management, LLC 416,670$3,125,0000.29%
Cormorant Asset Management, LP 454,550$3,409,0000.28%
SPHERA FUNDS MANAGEMENT LTD. 309,400$2,321,0000.26%
Artal Group S.A. 600,000$4,500,0000.17%
Perceptive Advisors 435,000$3,167,0000.12%
View complete list of TRANSLATE BIO INC shareholders